Minreksav (Cytisinicline)

Minreksav is a nicotinic receptor‑targeting agent used in the management of tobacco‑related disorders.

• Smoking cessation: reduces cravings and withdrawal symptoms to help patients quit smoking.
• Nicotine dependence: supports long‑term abstinence by moderating nicotine reward pathways.
• Tobacco use disorder: assists in decreasing daily tobacco consumption and preventing relapse.

• Cytisinicline acts as a partial agonist at the α4β2 subtype of nicotinic acetylcholine receptors in the central nervous system. By binding to these receptors it provides enough stimulation to lessen withdrawal while simultaneously blocking nicotine from fully activating the same sites, thereby reducing cravings and the reinforcing effects of tobacco use.

Cytisinicline may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Headache: intermittent tension‑type pain.
• Insomnia: difficulty falling or staying asleep.
• Vivid dreams: unusually intense or memorable dreams.
• Dizziness: light‑headed sensation, especially on standing.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with rash, swelling, or breathing difficulty.
• Mood changes: depression, anxiety, or irritability.
• Chest pain: unexplained thoracic discomfort.
• Cardiac arrhythmia: irregular heart rhythm.
• Seizures: convulsive episodes.
• Severe hypotension: marked drop in blood pressure.

Before initiating Minreksav, several safety considerations should be reviewed.

• Cardiovascular assessment: evaluate patients with recent heart disease or uncontrolled hypertension.
• Psychiatric monitoring: watch for new or worsening mood disorders.
• Liver function: use caution in moderate to severe hepatic impairment.
• Pregnancy and lactation: safety not established; weigh potential benefits against risks.
• Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously.
• Store at room temperature: keep in the original container, protect from moisture and light.

Cytisinicline can interact with several medication classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive crisis.
• Strong CYP2D6 inhibitors: can increase Cytisinicline plasma concentrations.
• Other nicotine replacement therapies: additive nicotine effect may increase toxicity.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors (SSRIs): may exacerbate insomnia.
• Antihypertensive agents: possible attenuation of blood‑pressure control.
• Alcohol: may enhance central nervous system depression.